KELLY FLORES: Open Payments
NPI 1184003402 · MERCED, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,360 in 74 payments from 12 companies in 2025. Trend: 2023 $22 · 2024 $304 · 2025 $1,360
Food & beverage: $1,280Education: $80
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. | 13 | $261 |
| Janssen Biotech, Inc. | 17 | $255 |
| Incyte Corporation | 13 | $202 |
| ABBVIE INC. | 13 | $181 |
| Novartis Pharmaceuticals Corporation | 5 | $141 |
| Organon LLC | 4 | $103 |
| PFIZER INC. | 3 | $87 |
| UCB, Inc. | 1 | $36 |
| GENZYME CORPORATION | 2 | $35 |
| Pharmacosmos Therapeutics Inc. | 1 | $26 |
Products named: EXCELSIUS GPS, TREMFYA, OPZELURA, SKYRIZI, VTAMA, CIBINQO, COSENTYX, Rhapsido.
Industry payments across CA — which companies pay providers there.
